Stefan Rozmanowski

COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study

James J. Clark, Panneerselvam, T. Roques, 2022, European Journal of Cancer.

SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission

A. Charlett, A. Walker, T. Peto, 2021, medRxiv.

An observational study of SARS-CoV-2 infectivity by viral load and 1 demographic factors and the utility lateral flow devices to prevent 2 transmission 3 4

A. Charlett, A. Walker, D. Crook, 2021 .

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.

T. Roques, S. Grumett, M. Middleton, 2022, JAMA oncology.

Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study

James J. Clark, T. Roques, T. Robinson, 2022, The Lancet Oncology.

A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)

T. Roques, S. Grumett, R. Roylance, 2023, Scientific reports.